US approves Vertex/CRISPR gene therapy to treat inherited blood disorder

U.S. health regulator has approved Vertex Pharmaceuticals’ CRISPR Therapeutics’. A gene therapy to treat a rare blood disorder requiring regular blood transfusions in patients 12 years of age and older, Vertex said Tuesday.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM